A method is described that allows electron microscopic identification of the phenothiazine neuroleptic promethazine after supravital intracardiac injection of high drug concentrations (23 "10). The cerebellar cortex of the mouse was used for the investigation. This procedure is based on simultaneous fmtion of drug and tissue by immersion in a paraformaldehyde-glutaraldehyde solution with the addition of phosphomolybdic acid. The electron microscopic investigation revealed that the drug could easily be identified as an electron-dense precipitate. Subpopulations of neurons exhibited a higher affinity for the drug than others, but no preference for any nerve cell type was detected. Closer study Mainz D-55099 Mainz, Germany. 21. Tsuji S. Yokoyama S: Electron microscopical localization of methylene blue staining in myenteric plexus. Biomed Res 2:693-698, 1981 22. Zhang L, Tardy M, Berry JP, Escaig F, Galle P: Localisation de deux molecules neurotropes dam les cellules gliales en culture par microscopie ionique. C R Acad Sci Paris [SErie 1111 314:55-60. 1992
Introduction
Different phenothiazine derivatives are used as neuroleptics in hypnotic and sedative therapy. In neurons, the plasma membrane and the intracellular membranes of cell organelles are considered to be the main targets of these drugs ( 5 ) . This binding behavior is followed by perturbations of different functions of the membranes (8). Although multiple ultrastructural changes induced by phenothiazine treatment have been identified by electron microscopy (16,18,19) , the intracellular storage of phenothiazines has been successfully visualized at the light microscopic level only once. This was done by applying fluorine-containing phenothiazines to monolayers of cultured cells, with subsequent ion microscopy (22) . Ultrastructural demonstration of phenothiazine binding has thus far been unsuccessful because phenothiazine neuroleptics are electron-lucent and extremely alcohol-soluble; the later property causes dislocation and loss of the drug during dehydration.
Methylene blue, a cationic phenothiazine dye, was introduced showed that promethazine accumulated primarily within the cytoplasm, where it was bound to the endoplasmic reticulum. Furthermore, promethazine storage was observed within mitochondria and vesiculat structures. Drug binding was also seen in the regions of synapses but without any predilection for these structures. b u s e this precipitation technique also appears to be well-suited for the ultrastructural identifcation of other drugs, it offers multiple possibilities for application. in microscopic neuroanatomy as a vital dye for visualization of nerve cells and their processes. Because all phenothiazine dyes possess a selective staining behavior for neuronal structures, although to different degrees, they were originally called "neurotrope dyes" (3). Subsequently, methylene blue supravital staining became established as a routine method in neurohistology (12) . In addition, the dye was also successfully administered in antipsychotic therapy (15). Recently, a method was introduced that enables the investigator to detect methylene blue in cytoplasm and cell nuclei by electron microscopy. This technique is based on simultaneous fixation of dye and tissue by immersion in a paraformaldehyde-glutaraldehyde solution with the addition of phosphomolybdic acid, followed by further stabilization of the ensuing electron-dense dye precipitate by ammonium heptamolybdate (11,13). The aim of the present study was to apply this method to the ultrastructural determination of the colorless phenothiazine neuroleptic promethazine (PMZ). Because of its relatively simple cytoarchitecture, the cerebellar cortex of the mouse was used for the investigation.
Materials and Methods
' were used for the experiments. The animals were sacrificed with diethyl ether. Their chests were opened by incision and ml of an aqueous solution of PMZ hydrochloride (Fluka; Buchs, Switzerland) was injected into the left cardiac ventricles. The concentration of the drug solution ranged from 2% to 30%. Some tissues were also treated without PMZ and served as controls. After 30 min at 20"C, the cerebellar cortices were removed and prepared as described elsewhere for tissues supravitally stained with methylene blue (13.14).
The first fixation was performed at 4°C for 2 hr 30 min [stock solution: 100 ml of 2 % paraformaldehyde and 1.75% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) containing 1.8% phosphomolybdic acid (final pH S)]. After a short rinse in distilled water, a second fixation took place in 5% aqueous ammonium heptamolybdate for 5 hr at 4'C. Subsequently, the tissues were washed in distilled water overnight. Then a third immersion was carried out in an aqueous mixture of 0.5% osmium tetroxide and 0.5% phosphomolybdic acid for 1 hr at 4°C. The specimens were subsequently washed overnight in distilled water.
Dehydration was performed in 100% tertiary butanol (melting point 25°C) for 24 hr. The first alcohol change was performed after 15 min, the second after 1 hr, and the third after 7 hr. Then the specimens were transferred for 1 hr to pure ethanol, which was changed several times. Subsequently, the tissues were embedded in Araldite (Fluka) . Ultrathin sections were viewed with an EM 300 electron microscope (Philips; Eindhoven, The Netherlands). Counterstaining with heavy metal salts was omitted to diminish the formation of unspecific electron-dense precipitates.
In addition, the PMZ-precipitating properties of the fixation solutions were verified in vitro. The arising precipitate was filtered off and the desired nondissolubility of the precipitate within the dehydration and embedding media was also tested.
Results
The in vitro tests showed that PMZ was immediately transformed to a precipitate by the fixation procedure. The filtered precipitate was insoluble in tertiary butanol. It also remained stable during the subsequent treatment steps in pure ethanol, propylene oxide, and Araldite.
Electron microscopic investigation revealed that the sections of the controls treated without PMZ showed only slight degenerative changes of the ultrastructure caused by the delay between death and fixation ( Figure 3) . Examination of the ultrathin sections obtained from tissues treated with PMZ concentrations of 23% revealed that the drug was present as an electron-dense precipitate (Figures 1, 2, and 4 ). The injection of lower concentrations of PMZ decreased the drug accumulations so that their detection became more difficult. In the case of the highest PMZ concentrauons (30%), the ultrastructure was significantly damaged; the drug had completely filled the cytoplasm of single nerve cells, whereas only little precipitate could be detected within the nuclei. Some nerve cells exhibited a higher affinity for the drug than others. In particular, the staining pattern was irregular; it did not show any preference of PMZ for any morphological cerebellar cell type (Figure 1 ). At lower but still relatively high drug concentrations (10%). the ultrastructure was also completely destroyed. The drug was identified as grainy, ring-shaped arranged precipitates, possibly marking the dilated endoplasmic reticulum which had also lost its continuity (Figure 2) . If a 3% PMZ solution had been injected, the ultrastructure was relatively well preserved ( Figure 4) . Here, PMZ had accumulated mainly at the endoplasmic reticulum, including the perinuclear space, as a fine-grained precipitate (Figure 4b ). It was also present within mitochondria and large vesicular structures (Figures 4c and 4d ). However, not all mitochondria showed visible PMZ uptake (Figure 4d ). In addition, PMZ accumulations were seen within neuronal processes (Figure 4e ). Drug storage was also detected in the regions of synapses but without any predilection for these structures compared to other neuronal compartments (Figure -if) .
Discussion
The most significant result of the present study was the intracellular identification of PMZ as an electron-dense precipitate resulting from a primary reaction with phosphomolybdic acid. In a former study, molybdic and tungstic heteropolyanions were found to transform the cationic phenothiazine dye methylene blue to water-and alcohol-insoluble blue reaction products, thus permitting the production of microtome sections with no fading of the stain (1) . Staining of the axolemma of peripheral nerve fibers by methylene blue was found by electron microscopy after precipitation of the dye by sodium silicotungstate to an electron-dense reaction product (21) . Moreover, an ultrastructural visualization of acetylcholine in synaptic vesicles at motor endplates became possible via the use of the methylene blue-precipitating reagent phosphomolybdic acid. The term "ionic fixation" was coined for this procedure (20) . It should be pointed out here that anionic complexes of metals are also used in analytical chemistry for the precipitation of phenothiazine neuroleptics to water-insoluble reaction products and subsequent indirect determination of the phenothiazine with extractive spectrophotometric methods (for review see 17).
A further important finding of this study was the observation that the drug mainly accumulated at the endoplasmic reticulum and was also stored within mitochondria and large vesicular structures. This binding behavior is in full accordance with the investigations of ultrastructural changes after administration of different phenothiazines; dilatations of the endoplasmic reticulum combined with the loss of its continuity and morphological alterations of mitochondria and other cell organelles have been observed (16, 18, 19) .
The observed phenomenon that the drug was also stored in the regions of synapses supports former studies which proved an interaction of phenothiazines with synaptosomal membranes (2). However, the additionally detected PMZ accumulations in cell processes outside synapses suggest that synapses do not represent preferential targets for the drug.
Summarizing the observed drug accumulations, the staining pattern appears to be similar to that of a cationic dye. In addition, the results of this study also corroborate former light microscopic findings showing that phenothiazines are primarily stored within the cytoplasm, contrary to the intracellular high affinity of benzodiazepines for the nucleus (22).
Although a specific receptor has not been previously found, a series of structures are considered to be involved in phenothiazines uptake: different mitochondrial enzymes are altered in their function by the drug's binding (4). Furthermore, the synthesis of cyclic adenosine monophosphate is decreased by phenothiazines (6). Dopamine receptors can be inhibited by phenothiazines (7). It has also been shown that these drugs antagonize the calcium binding protein calmodulin (9). In addition, protein kinase C is -. Figure 4 Treatment with 3% PMZ Purkinje cell layer (a) The ultrastructure of a Purkinje cell (Pc) and the adjacent neuropil has been preserved (b) The drug has accumulated primarily at the perinuclear space (arrow) delineating the nucleus (N) and at the endoplasmic reticulum (arrowhead) (c) PMZ has bound to mitochondria (arrowheads), the adjacent nucleus (N) showsonlya few precipitates (d) In the cytoplasm PMZcan also beobserved within large vesicular structures (arrow) (e) A dendrite of a Purkinje cell shows drug accumulations (arrow) mainly outside of mitochondria (1) The drug precipitates (arrows) can also be detected in Ihe region of synapses (arrowheads) but without any predilection for these structures Original magnificalions a x 3000 b,e x 26000 c x 38 000 d x 22 000 f x 53000 Bars a = 5 r i m b-e = 0 5 1 i m f = O25rim I also directly inhibited by phenothiazines (10) . An influence on the function of membrane-bound alkaline phosphatase was also observed (14). Although any conclusions regarding pharmacological phenothiazine effects drawn from a purely cytochemical investiga-tion should be carefully limited, the mentioned well-known functional changes of membranes would be explained by the different intracellular accumulation sites of PMZ found in the present study.
DEMONSTRATION OF PROMETHAZINE ACCUMULATION SITES
It must be emphasized, however, that the results of the present study were not achieved under physiological (i.e., therapeutic) conditions, because the animals were perfused with high and therefore toxic doses of the neuroleptic. In this context, it cannot completely be excluded that the detected heterogeneous distribution pattern of the drug displayed by the lack of preference for any identifiable cell type was caused by the method of PMZ application. Contrary to this interpretation, the differences in the drug uptake between neighboring cells might also be based on their putative varying affinities to PMZ. Because the latter assumption could not be tested under physiological conditions, any conclusion regarding therapeutic effects would represent a matter of speculation and cannot be verified by a simple electron microscopic investigation. The same problem has to be discussed in the light of the demonstrated differences in mitochondrial staining, which may take place only during particular phases of drug uptake. Therefore, the observations obtained must be interpreted with care. Nevertheless, they represent the first data regarding direct visualization of the intracellular binding behavior of a colorless phenothiazine neuroleptic at the ultrastructural level. Because the precipitation technique demonstrated here is most probably also well-suited for electron microscopic identification of other phenothiazine neuroleptics and low molecular weight organic substances, it offers multiple possibilities for application, especially for the ultrastructural visualization of different drugs in different tissues under supravital conditions.
